Oaktree Capital Management BAK trades
Howard Marks
Howard Marks Braskem SA, CL-A stake
total: 853
Trades details
- Total transactions:
- 9
- New positions:
- 2
- Sold out:
- 2
- Added:
- 3
- Reduced:
- 2
- Held since:
- 2024 Q1
- Held for:
- 6 quarters
- Latest activity:
- 2025 Q3
According to 2026 Q2 report, Howard Marks doesn't hold any Braskem SA, CL-A (BAK) shares. To date, the estimated cost basis is nearly $9.79 for "buy" trades and estimated average "sell" price is $3.31. Oaktree Capital Management first purchased BAK in 2020 Q1, initially acquiring 279,550 shares. Howard Marks later completely sold out the position and invested in Braskem SA, CL-A again in 2024 Q1. Since the initial investment in Braskem SA, CL-A (BAK), Oaktree Capital Management has made 8 more transactions.
When did Howard Marks sell Braskem SA, CL-A (BAK)?
Howard Marks sold off the entire Braskem SA, CL-A (BAK) position in 2025 Q3.
When did Howard Marks buy Braskem SA, CL-A (BAK)?
Howard Marks first invested in Braskem SA, CL-A (BAK) in 2020 Q1 at the reported quarter-end price of $6.64 per share.
What's the cost basis of Oaktree Capital Management's BAK stake?
The estimated cost basis for Braskem SA, CL-A (BAK) stake is around $9.79 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $9.79
- Weighted AVG sell price:
- $3.31
Howard Marks's historical trades in Braskem SA, CL-A
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
0.00%
|
0
|
$3.28
|
|
-100% (-453,167)
|
-0.03%
|
|
2025 Q2
|
0.03%
|
453,167
|
$3.28
|
$1,486,387
|
-80.67% (-1,891,125)
|
-0.13%
|
|
2025 Q1
|
0.18%
|
2,344,292
|
$3.85
|
$9,025,524
|
-5.92% (-147,500)
|
-0.01%
|
|
2024 Q3
|
0.30%
|
2,491,792
|
$7.34
|
$18,289,753
|
+1.99% (+48,524)
|
+0.01%
|
|
2024 Q2
|
0.27%
|
2,443,268
|
$6.45
|
$15,759,078
|
+20.55% (+416,476)
|
+0.05%
|
|
2024 Q1
|
0.34%
|
2,026,792
|
$10.53
|
$21,342,119
|
new
|
+0.34%
|
|
2021 Q4
|
0.00%
|
0
|
$21.83
|
|
-100% (-519,550)
|
-0.17%
|
|
2020 Q2
|
0.10%
|
$8.65
|
+85.85% (+240,000)
|
|||
|
2020 Q1
|
0.05%
|
$6.64
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.